Dana Investment Advisors’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $549K | Sell |
16,602
-401
| -2% | -$13.2K | 0.02% | 444 |
|
|
2025
Q1 | $683K | Buy |
17,003
+140
| +0.8% | +$5.63K | 0.02% | 415 |
|
|
2024
Q4 | $793K | Sell |
16,863
-169
| -1% | -$7.95K | 0.03% | 415 |
|
|
2024
Q3 | $899K | Buy |
17,032
+1,082
| +7% | +$57.1K | 0.03% | 393 |
|
|
2024
Q2 | $864K | Sell |
15,950
-35
| -0.2% | -$1.9K | 0.03% | 390 |
|
|
2024
Q1 | $1.12M | Sell |
15,985
-1,136
| -7% | -$79.6K | 0.04% | 361 |
|
|
2023
Q4 | $1.43M | Sell |
17,121
-1,295
| -7% | -$108K | 0.07% | 208 |
|
|
2023
Q3 | $543K | Sell |
18,416
-1,829
| -9% | -$53.9K | 0.03% | 298 |
|
|
2023
Q2 | $660K | Buy |
20,245
+295
| +1% | +$9.62K | 0.03% | 286 |
|
|
2023
Q1 | $702K | Buy |
19,950
+1,349
| +7% | +$47.5K | 0.04% | 278 |
|
|
2022
Q4 | $852K | Buy |
18,601
+2,994
| +19% | +$137K | 0.04% | 250 |
|
|
2022
Q3 | $756K | Sell |
15,607
-211
| -1% | -$10.2K | 0.04% | 252 |
|
|
2022
Q2 | $621K | Sell |
15,818
-1,533
| -9% | -$60.2K | 0.03% | 287 |
|
|
2022
Q1 | $639K | Buy |
17,351
+489
| +3% | +$18K | 0.03% | 251 |
|
|
2021
Q4 | $769K | Sell |
16,862
-2,483
| -13% | -$113K | 0.03% | 232 |
|
|
2021
Q3 | $691K | Sell |
19,345
-5,866
| -23% | -$210K | 0.03% | 228 |
|
|
2021
Q2 | $499K | Sell |
25,211
-111
| -0.4% | -$2.2K | 0.02% | 250 |
|
|
2021
Q1 | $589K | Buy |
+25,322
| New | +$589K | 0.03% | 242 |
|